Backing for new bacteria drug plan

Drugs that neutralise bacteria rather than killing them may be the key to stopping the spread of resistant strains, Scottish experts say.

The new kind of drugs, known as anti-virulence drugs, could provide an "effective and longer-lasting" means of tackling resistance, according to experts at Edinburgh University.

The drugs are designed to deactivate the parts of bacteria that make people ill without killing them.

Richard Allen, from Edinburgh University’s school of biological sciences, has published a review of research in the area over the last five years.

Reporting in Nature Reviews Microbiology, he says clinical trials have shown positive results.

He said: "Our findings reveal that there are opportunities to make real progress in the fight against antibiotic resistance.

"Gaining a greater understanding of how virulence affects bacterial growth in the host should aid us in our efforts to develop effective anti-virulence drugs."

Nature Reviews Microbiology March 2014

,

Leave a Reply

Your email address will not be published. Required fields are marked *

Search

Categories

Monthly Posts

Our Clients

BSH
Practice Index